Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Lyra Therapeutics, Inc. (LYRA) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Lyra Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1327273.
Total stock buying since 2020: $94,684,567.
Total stock sales since 2020: $1,219,222.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 2,249 | $20,038 | 0 | $0 |
| 2023 | 10,857,496 | $26,624,544 | 0 | $0 | 0 | $0 |
| 2022 | 11,026,781 | $46,538,665 | 0 | $0 | 0 | $0 |
| 2021 | 3,500 | $31,395 | 0 | $0 | 0 | $0 |
| 2020 | 1,343,525 | $21,489,963 | 74,949 | $1,199,184 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 2,249 | $20,038 | 0 | $0 |
| 2023-11 | 25,000 | $74,100 | 0 | $0 | 0 | $0 |
| 2023-05 | 10,832,496 | $26,550,444 | 0 | $0 | 0 | $0 |
| 2022-06 | 4,000 | $20,200 | 0 | $0 | 0 | $0 |
| 2022-05 | 3,828 | $18,485 | 0 | $0 | 0 | $0 |
| 2022-04 | 11,018,953 | $46,499,980 | 0 | $0 | 0 | $0 |
| 2021-06 | 3,500 | $31,395 | 0 | $0 | 0 | $0 |
| 2020-12 | 1,025 | $9,963 | 0 | $0 | 0 | $0 |
| 2020-05 | 1,342,500 | $21,480,000 | 74,949 | $1,199,184 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-10 | Cavalier Jason (Chief Financial Officer) | Sale | 684 | 8.91 | 6,094 |
| 2025-07-10 | Palasis Maria (President & CEO) | Sale | 1,565 | 8.91 | 13,944 |
| 2023-11-10 | Waksal Harlan (Executive Chair) | Buy | 25,000 | 2.96 | 74,100 |
| 2023-05-31 | North Bridge Venture Management Vi, L.p. (10% Owner) | Buy | 3,610,832 | 2.43 | 8,774,320 |
| 2023-05-31 | Anderson Edward T (Director) | Buy | 1,805,416 | 2.43 | 4,387,160 |
| 2023-05-31 | Edelman Joseph (Director) | Buy | 3,610,832 | 2.49 | 9,001,804 |
| 2022-06-10 | Merrifield C Ann (Director) | Buy | 4,000 | 5.05 | 20,200 |
| 2022-05-16 | Merrifield C Ann (Director) | Buy | 328 | 5.00 | 1,640 |
| 2022-05-13 | Merrifield C Ann (Director) | Buy | 3,500 | 4.81 | 16,845 |
| 2022-04-12 | North Bridge Venture Management Vi, L.p. (10% Owner) | Buy | 2,369,667 | 4.22 | 9,999,994 |
| 2022-04-12 | Waksal Harlan (Executive Chair) | Buy | 236,966 | 4.22 | 999,996 |
| 2022-04-12 | Anderson Edward T (Director) | Buy | 2,488,150 | 4.22 | 10,499,993 |
| 2022-04-12 | Edelman Joseph (Director) | Buy | 5,924,170 | 4.22 | 24,999,997 |
| 2021-06-17 | Merrifield C Ann (Director) | Buy | 3,500 | 8.97 | 31,395 |
| 2020-12-16 | Snyderman Nancy Lynn Md (Director) | Buy | 1,025 | 9.72 | 9,963 |
| 2020-05-05 | Levy Guy | Buy | 155,000 | 16.00 | 2,480,000 |
| 2020-05-05 | Levy Guy | Sale | 16,909 | 16.00 | 270,544 |
| 2020-05-05 | North Bridge Venture Management Vi, L.p. (10% Owner) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-05-05 | North Bridge Venture Management Vi, L.p. (10% Owner) | Sale | 24,183 | 16.00 | 386,928 |
| 2020-05-05 | Flint Jonathan A (10% Owner) | Buy | 62,500 | 16.00 | 1,000,000 |
| 2020-05-05 | Flint Jonathan A (10% Owner) | Sale | 9,674 | 16.00 | 154,784 |
| 2020-05-05 | Anderson Edward T (Director) | Buy | 250,000 | 16.00 | 4,000,000 |
| 2020-05-05 | Anderson Edward T (Director) | Sale | 24,183 | 16.00 | 386,928 |
| 2020-05-05 | Edelman Joseph (Director) | Buy | 625,000 | 16.00 | 10,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of LYRA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Lyra Therapeutics, Inc. (symbol LYRA, CIK number 1327273) see the Securities and Exchange Commission (SEC) website.